Labcorp on Wednesday began marketing to US physicians the first test for a trio of blood biomarkers it says can detect the hallmarks of Alzheimer’s, accelerating diagnosis of the brain-wasting disease and potentially helping patients access treatment. Labcorp’s Amyloid-Tau-Neurodegeneration (ATN) Profile is not precise enough to definitively diagnose Alzheimer’s, but offers a convenient way for doctors to determine which patients …
Read More »3-part blood test for Alzheimer’s
October 12, 2023